更多文章
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
1 年
Newly launched TCR company ALKemist Bio announces a €6.9M Investment Round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors.
1 年
LIFTT and Techstars Transformative World Torino team up for the growth of deep-tech start-ups
1 年